Hwail Pharm Co (XKRX:061250) Interest Expense : ₩-21 Mil (TTM As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hwail Pharm Co's interest expense for the three months ended in Mar. 2024 was ₩ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-21 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hwail Pharm Co's Operating Income for the three months ended in Mar. 2024 was ₩ 803 Mil. Hwail Pharm Co's Interest Expense for the three months ended in Mar. 2024 was ₩ -4 Mil. Hwail Pharm Co's Interest Coverage for the quarter that ended in Mar. 2024 was 199.82. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hwail Pharm Co Interest Expense Historical Data

The historical data trend for Hwail Pharm Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Interest Expense Chart

Hwail Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-293.25

-137.48

-115.81

-11.42

-18.94

Hwail Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-2.45	-3.66	-51.20	38.36	-4.02

Hwail Pharm Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-21 Mil.

Hwail Pharm Co (XKRX:061250) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hwail Pharm Co's Interest Expense for the three months ended in Mar. 2024 was ₩-4 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩803 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩176 Mil.

Hwail Pharm Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	803.268	/	-4.02
	=	199.82

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Hwail Pharm Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Hwail Pharm Co (XKRX:061250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746

Website

http://www.hwail.com

Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines